The Ultra PC% is used to control the flow of gases in a nitrous oxide-oxygen sedation system, mostly during dental procedures. However, when not mixed with oxygen, nitrous oxide can lead to temporary and permanent brain damage or death when inhaled.
Accutron voluntarily recalled the product. Though two complaints have been received about the defect, no injuries have been reported. Healthcare and anesthesia providers should report adverse effects or side effects to the FDA’s MedWatch Safety Information program.
More Articles on Anesthesia:
Nerve Blocks: Do They Increase or Decrease OR Efficiency?
Covidien Respiratory Monitoring Study Presented at ASA Meeting
Significant Changes for Anesthesia Ahead: How Will Your Career be Impacted?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
